Log in

NASDAQ:AMEH - Apollo Medical Stock Price, Forecast & News

$17.15
-0.33 (-1.89 %)
(As of 02/17/2020 01:07 AM ET)
Today's Range
$17.00
Now: $17.15
$17.79
50-Day Range
$17.15
MA: $18.18
$18.88
52-Week Range
$13.02
Now: $17.15
$23.26
Volume38,713 shs
Average Volume54,851 shs
Market Capitalization$598.36 million
P/E Ratio155.92
Dividend YieldN/A
Beta-0.85
Apollo Medical Holdings, Inc., a physician-centric integrated population health management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network consists of primary care physicians, specialist physicians, and hospitalists. The company serves the patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organizations; and non-insured patients in California. Apollo Medical Holdings, Inc. was founded in 1994 and is headquartered in Alhambra, California.

Industry, Sector and Symbol

Industry Management consulting services
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:AMEH
CUSIPN/A
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$519.91 million
Cash Flow$0.98 per share
Book Value$5.33 per share

Profitability

Net Income$10.84 million

Miscellaneous

Employees475
Market Cap$598.36 million
Next Earnings Date3/16/2020 (Estimated)
OptionableNot Optionable

Receive AMEH News and Ratings via Email

Sign-up to receive the latest news and ratings for AMEH and its competitors with MarketBeat's FREE daily newsletter.


Apollo Medical (NASDAQ:AMEH) Frequently Asked Questions

What is Apollo Medical's stock symbol?

Apollo Medical trades on the NASDAQ under the ticker symbol "AMEH."

How were Apollo Medical's earnings last quarter?

Apollo Medical Holdings Inc (NASDAQ:AMEH) announced its earnings results on Wednesday, November, 14th. The company reported $0.24 EPS for the quarter, topping the consensus estimate of $0.09 by $0.15. The firm had revenue of $167.28 million for the quarter. Apollo Medical had a net margin of 0.88% and a return on equity of 3.16%. View Apollo Medical's Earnings History.

When is Apollo Medical's next earnings date?

Apollo Medical is scheduled to release their next quarterly earnings announcement on Monday, March 16th 2020. View Earnings Estimates for Apollo Medical.

Has Apollo Medical been receiving favorable news coverage?

News headlines about AMEH stock have trended somewhat positive on Monday, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Apollo Medical earned a coverage optimism score of 2.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Apollo Medical.

Are investors shorting Apollo Medical?

Apollo Medical saw a decrease in short interest in January. As of January 31st, there was short interest totalling 755,700 shares, a decrease of 13.4% from the January 15th total of 872,600 shares. Based on an average trading volume of 123,900 shares, the short-interest ratio is currently 6.1 days. Currently, 8.8% of the company's shares are short sold. View Apollo Medical's Current Options Chain.

What other stocks do shareholders of Apollo Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Medical investors own include NVIDIA (NVDA), Trade Desk (TTD), Paypal (PYPL), Gilead Sciences (GILD), SEA (SE), Alibaba Group (BABA), Bristol-Myers Squibb (BMY), salesforce.com (CRM), Mastercard (MA) and Advanced Micro Devices (AMD).

Who are Apollo Medical's key executives?

Apollo Medical's management team includes the folowing people:
  • Dr. Kenneth T. Sim M.D., Exec. Chairman
  • Dr. Thomas S. Lam, CEO & Director (Age 70)
  • Mr. Eric Chin, Chief Financial Officer
  • Mr. Hing Ang, Chief Operating Officer
  • Dr. Albert Young M.D., Co-Chief Medical Officer

Who are Apollo Medical's major shareholders?

Apollo Medical's stock is owned by many different of retail and institutional investors. Top institutional investors include State Street Corp (0.66%), THB Asset Management (0.39%), Charles Schwab Investment Management Inc. (0.31%), Bank of New York Mellon Corp (0.18%), Virginia Retirement Systems ET AL (0.17%) and Martingale Asset Management L P (0.16%). Company insiders that own Apollo Medical stock include Adrian Vazquez, Albert Waichow Young, Eric Chin, John Chiang, Kenneth T Sim, Mark Fawcett, Michael F Eng, Physicians Of Californi Allied, Thomas S Lam and Warren Hosseinion. View Institutional Ownership Trends for Apollo Medical.

Which major investors are selling Apollo Medical stock?

AMEH stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, Goldman Sachs Group Inc., Charles Schwab Investment Management Inc., Bank of New York Mellon Corp, New York State Common Retirement Fund, Rhumbline Advisers, American International Group Inc. and Barclays PLC. View Insider Buying and Selling for Apollo Medical.

Which major investors are buying Apollo Medical stock?

AMEH stock was purchased by a variety of institutional investors in the last quarter, including Virginia Retirement Systems ET AL, Martingale Asset Management L P, Cubist Systematic Strategies LLC, UBS Asset Management Americas Inc., Bessemer Group Inc., THB Asset Management, Panagora Asset Management Inc. and Zurcher Kantonalbank Zurich Cantonalbank. Company insiders that have bought Apollo Medical stock in the last two years include Albert Waichow Young, Eric Chin, John Chiang, Kenneth T Sim, Mark Fawcett, Michael F Eng, Physicians Of Californi Allied and Thomas S Lam. View Insider Buying and Selling for Apollo Medical.

How do I buy shares of Apollo Medical?

Shares of AMEH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Apollo Medical's stock price today?

One share of AMEH stock can currently be purchased for approximately $17.15.

How big of a company is Apollo Medical?

Apollo Medical has a market capitalization of $598.36 million and generates $519.91 million in revenue each year. The company earns $10.84 million in net income (profit) each year or $0.29 on an earnings per share basis. Apollo Medical employs 475 workers across the globe.View Additional Information About Apollo Medical.


MarketBeat Community Rating for Apollo Medical (NASDAQ AMEH)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  114 (Vote Outperform)
Underperform Votes:  137 (Vote Underperform)
Total Votes:  251
MarketBeat's community ratings are surveys of what our community members think about Apollo Medical and other stocks. Vote "Outperform" if you believe AMEH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AMEH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/17/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel